Phase I-II Prospective Trial, Multicenter, Open Label, Exploring the Combination of Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients
Phase of Trial: Phase I/II
Latest Information Update: 02 Jun 2017
At a glance
- Drugs Trabectedin (Primary)
- Indications Leiomyosarcoma; Liposarcoma; Soft tissue sarcoma
- Focus Therapeutic Use
- Acronyms TRASTS
- 02 Jun 2017 Results of phase I part of this study (n=14) presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 19 May 2017 According to a PharmaMar media release, data from this trial will be presented at the 53rd Congress of the American Society of Clinical Oncology (ASCO) 2017.
- 22 Feb 2017 Planned End Date changed from 1 Mar 2017 to 1 Jun 2018.